Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Dermatology Drugs Market Global Briefing 2017

Dermatology Drugs Market Global Briefing 2017

From $1,000.00

Including: Dermatology Drugs
Covering: Johnson & Johnson, Allergan Plc., Galderma S.A., Novartis AG, GlaxosmithKline Plc., Bayer AG, LEO Pharma A/S


Clear selection
SKU: 2273. Categories: , .
Description

North America was the largest region in the dermatology drugs market in 2016, accounting for over 30% market share. This can be attributed to large number of affluent patients and generous reimbursement within the US pharma market. Asia Pacific was the second largest region accounting for around 29% market share. Western Europe was the third largest region accounting for around 15% market share.

Dermatology Drugs Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the dermatology drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the dermatology drugs market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the dermatology drugs market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.

 

Scope

Markets Covered: Dermatology Drugs
Companies Mentioned: Johnson & Johnson, Allergan Plc., Galderma S.A., Novartis AG, GlaxosmithKline Plc., Bayer AG, LEO Pharma A/S
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

 

Executive Summary
The dermatology drugs market includes medications that are used for the treatment of skin conditions such as dermatitis (including eczema), rosacea, hyperhidrosis, androgenic alopecia, onychomycosis, hair loss, acne, immune disorders (including psoriasis), microbial infections (bacterial, fungal, and viral), vascular and pigmented lesion removal, common warts, seborrheic keratosis, and other skin diseases.

The global dermatology drugs market is expected to reach over $35 billion in 2020. Going forward, increase in the number of indications treated by topical drugs coupled with increase in acne and rosacea patients will drive the market for dermatology drugs.

Immune Modulators To Treat Eczema - Pharmaceutical companies are offering new drugs referred to as immune modulators for the treatment of skin diseases such as eczema. Eczema is a chronic skin condition caused by the lack of skin proteins that results in inflammation and irritation in the skin. These drugs are used to externally treat the skin without changing the immune system of the body. In addition, unlike topical steroids, these new medications do not cause thinning of the skin and breaking of superficial blood vessels. Tacrolimus (Protopic) and Pimecrolimus (Elidel) are major drugs available for the treatment of eczema.
Table of Contents
Dermatology Drugs Market Characteristics 4
Dermatology Drugs Market Historic Growth 6
Dermatology Drugs Market Forecast Growth 7
Dermatology Drugs Market Geography Regional and Country Comparison 8
Global Dermatology Drugs Market, Split By Regions, 2016 8
Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 10
Global Dermatology Drugs Market, Split By Country, 2016 12
Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 14
Dermatology Drugs Market Competitive Landscape 16
Johnson & Johnson 17
Galderma S.A. 17
Allergan Plc. 17
Novartis AG 17
GlaxosmithKline Plc. 17
Bayer AG 17
LEO Pharma A/S 17
Johnson & Johnson (J&J) 17
Allergan 18
Galderma S.A. 18
Dermatology Drugs Market Key Mergers And Acquisitions 20
Nestle Acquired Galderma 20
L'Oreal Acquired Valeant Pharmaceutical’s Dermatology Brands 20
LEO Pharma Acquired Astellas’ Dermatology Portfolio 20
Allergan Acquired Vitae Pharmaceuticals 20
Valeant Pharmaceuticals Acquire PreCision Dermatology, Inc. 20
Novartis Acquired Ziarco Group Limited 21
Zydus Acquired Issar Pharmas Melgain 21
Allergan Acquires Anterios 21
Dermatology Drugs Market Trends And Strategies 22
Immune Modulators To Treat Eczema 22
Genome Testing To Speed Clinical Trials Of Drugs 22
Increase In Mergers And Acquisitions Activity 22
Early Rx-To-OTC Switch 22
Biologics For Dermatology 23
Appendix 24
NAICS Definitions Of Industry Covered In This Report 24
Definition Of Market Covered In This Report 24
Abbreviations 24
Currencies 24
Research Methodology 25
Research Inquiries 26
The Business Research Company 26

List of Figures
Figure 1: Global Dermatology Drugs Market, Historic Market Size, 2012-2016, $ Billion 6
Figure 2: Global Dermatology Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 7
Figure 3: Global Dermatology Drugs Market, Split By Region, 2016, $ Billion 8
Figure 4: Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 10
Figure 5: Global Dermatology Drugs Market, Split By Country, 2016, $ Billion 12
Figure 6: Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 14
Figure 7: Global Dermatology Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 16

List of Tables
Table 1: Global Dermatology Drugs Market, Historic Market Size, 2012-2016, $ Billion 6
Table 2: Global Dermatology Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 7
Table 3: Global Dermatology Drugs Market, Split By Region, 2016, $ Billion 9
Table 4: Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 10
Table 5: Global Dermatology Drugs Market, Split By Country, 2016, $ Billion 12
Table 6: Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 14
Table 7: Global Dermatology Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 16
Get Customized Report
Please fill in your details. Our team will get back to you